/BMCS

BMCS Stock - BioTech Medics, Inc.

Q: What is the analyst price target for BMCS?

Analyst price target information is not currently available for BMCS.

Q: What is BMCS's market cap?

Market capitalization information is not currently available for BMCS.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.01+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BMCS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta3.66

52W High$0.02

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-2,919	$-4,687	$-115,150	$-322,560	$-154,230
Net Income	$-2,919	$-5,624	$-115,146	$-322,560	$-109,670
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$0.00	$0.00	$-0.00	$-0.00	$-0.00

Company Overview

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Visit Website

Frequently Asked Questions about BMCS

What is BMCS's current stock price?

BioTech Medics, Inc. (BMCS) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for BMCS?

No analyst price targets are currently available for this stock.

What sector is BioTech Medics, Inc. in?

BioTech Medics, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is BMCS's market cap?

BioTech Medics, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does BMCS pay dividends?

No, BioTech Medics, Inc. does not currently pay a dividend to shareholders.